cnpy3 Antibody

What is CNPY3 and what is its biological significance?

CNPY3 (Protein canopy homolog 3) functions as a co-chaperone in the endoplasmic reticulum (ER) and regulates the subcellular distribution and responses of multiple Toll-like receptors . The protein contains an N-terminal signal sequence, a domain of unknown function (DUF3456), and a putative C-terminal ER retention signal that is conserved in mammals . CNPY3 has several alternative names including PRAT4A, TNRC5, CTG4A, and ERDA5 . Recent research has revealed that CNPY3 plays essential roles in brain function beyond its known TLR-dependent immune responses, as biallelic variants in CNPY3 have been associated with early-onset epileptic encephalopathies including West syndrome .

What are the typical applications for CNPY3 antibodies in research?

CNPY3 antibodies can be employed in multiple research techniques:

• Western blotting (WB): Recommended dilution range of 1:500-1:2000

• Immunohistochemistry (IHC): Recommended dilution range of 1:50-1:200

• Protein localization studies

• Analysis of protein expression levels

• Investigation of protein-protein interactions

These applications allow researchers to study CNPY3's expression patterns, localization, and role in various cellular processes and disease models.

How should CNPY3 antibodies be stored and handled for optimal performance?

For optimal antibody performance, follow these storage and handling guidelines:

All handling should follow standard laboratory practices for antibody preservation, including sterile technique and minimal exposure to light .

What is the optimal sample preparation protocol for detecting CNPY3 in Western blotting?

For effective detection of CNPY3 in Western blotting:

• Lysate preparation:

  • Use a lysis buffer containing 50 mM Tris HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1 mM phenylmethanesulfonyl fluoride, and protease inhibitor cocktail

• Gel electrophoresis:

  • Use SDS-PAGE with 10-12% gels (CNPY3 has a calculated molecular weight of 30,748 Da)

• Antibody incubation:

  • Primary antibody: Dilute to 1:500-1:2000 range

  • Secondary antibody: Use appropriate anti-rabbit IgG conjugate

• Controls:

  • Include lymphoblastoid cell lines as potential controls, as they express detectable levels of CNPY3

How can I validate the specificity of a CNPY3 antibody?

Multiple validation approaches should be employed:

• Genetic validation:

  • Use of CNPY3-knockout models as negative controls

  • Comparison with samples known to have reduced CNPY3 expression (e.g., lymphoblastoid cells from individuals with CNPY3 variants)

• Expression analysis:

  • Compare observed protein size with theoretical molecular weight (30,748 Da)

  • Verify subcellular localization patterns against known ER distribution

• Epitope verification:

  • Consider the antibody's target region in relation to functional domains

  • For example, antibodies targeting the DUF3456 domain or C-terminal ER retention signal may provide different results

How do different CNPY3 variants affect antibody detection?

CNPY3 variants can significantly impact antibody detection:

How can CNPY3 antibodies be used to investigate its role in neurological disorders?

Research into CNPY3's neurological functions can be approached through:

• Expression analysis in neural tissues:

  • Compare CNPY3 levels between control and disease states

  • Correlate with phenotypic manifestations such as hippocampal malrotation observed in individuals with CNPY3 variants

• Animal model investigations:

  • CNPY3-knockout mice exhibit specific phenotypes:

    • Spastic or dystonic features under resting conditions

    • Hyperactivity and anxiolytic behavior during open field testing

    • EEG abnormalities with enhanced activity in the fast beta frequency band (20-35 Hz)

• Correlative studies:

  • Investigate CNPY3 expression in relation to seizure activity

  • The search results indicate that in individuals with CNPY3 variants, fast waves detected by EEG were clinically associated with seizures

What experimental considerations are important when using CNPY3 antibodies to study epilepsy models?

When investigating epilepsy models:

• Control selection:

  • Include wild-type controls alongside heterozygous and homozygous models

  • For pharmacological studies (e.g., pilocarpine-induced seizures), include appropriate vehicle controls

• EEG correlation:

  • CNPY3-knockout mice show enhanced activity in the fast beta frequency band (20-35 Hz)

  • This activity pattern may mimic the fast waves observed in individuals with CNPY3 variants

• Behavioral correlates:

  • Monitor for hyperactivity and anxiolytic behavior, which were observed in CNPY3-knockout mice

  • These behaviors are quantifiable through standardized tests like the open field test

• Technical parameters for EEG:

  • Signal electrode placement above sensorimotor cortex

  • Reference electrode on nasal bone

  • Ground electrode on interparietal bone

  • Signal amplification and digitization at appropriate frequencies (e.g., 4 kHz)

How can I design experiments to study CNPY3's interaction with Toll-like receptors?

To investigate CNPY3-TLR interactions:

• Co-localization studies:

  • Double immunostaining for CNPY3 and TLRs

  • Track ER retention versus cell surface expression of TLRs

• Functional assays:

  • Correlate CNPY3 levels with TLR signaling efficiency

  • Monitor downstream pathways (e.g., NF-κB activation)

• Protein-protein interaction analysis:

  • Immunoprecipitation using CNPY3 antibodies followed by TLR detection

  • Proximity ligation assays to visualize interactions in situ

What methodological challenges exist when studying CNPY3 in immune cell populations?

Several technical considerations should be addressed:

• Cell type-specific expression:

  • Validate antibody performance across different immune cell populations

  • Adjust protocols for primary cells versus cell lines

• Subcellular fractionation:

  • Effective separation of ER compartments where CNPY3 is primarily localized

  • Preservation of protein-protein interactions during isolation

• Stimulation conditions:

  • Monitor dynamic changes in CNPY3-TLR interactions under various stimuli

  • Include appropriate time-course analyses

What are common issues with Western blotting for CNPY3 and how can they be resolved?

How can I optimize immunohistochemistry protocols for CNPY3 detection in brain tissue?

For effective CNPY3 immunohistochemistry in neural tissues:

• Fixation considerations:

  • Perfusion fixation with 4% paraformaldehyde for optimal antigen preservation

  • Careful control of fixation time to prevent epitope masking

• Antigen retrieval optimization:

  • Heat-induced epitope retrieval with citrate buffer (pH 6.0)

  • Optimization of retrieval times for neural tissues

• Dilution testing:

  • Initial dilution range of 1:50-1:200 as recommended

  • Systematic optimization with serial dilutions

• Controls:

  • Include CNPY3-knockout tissues as negative controls

  • Consider hippocampal sections, as hippocampal malrotation was observed in individuals with CNPY3 variants

How might CNPY3 antibodies contribute to understanding ER stress responses?

As an ER co-chaperone, CNPY3 may play roles in ER stress pathways:

• Expression analysis under stress conditions:

  • Monitor CNPY3 levels after treatment with ER stressors

  • Compare with established ER stress markers

• Interaction studies:

  • Investigate associations with other ER chaperones and co-chaperones

  • Analyze potential roles in the unfolded protein response

• Neurological connections:

  • Explore links between ER stress, CNPY3 dysfunction, and epilepsy

  • Correlate with the phenotypes observed in CNPY3-knockout mice

What research opportunities exist for studying CNPY3 in developmental neurobiology?

The association of CNPY3 variants with developmental disorders suggests several research avenues:

• Developmental expression patterns:

  • Track CNPY3 expression throughout neural development

  • Correlate with hippocampal formation, given the malrotation phenotype

• Electrophysiological correlates:

  • Investigate how CNPY3 deficiency leads to EEG abnormalities

  • Study circuit-level alterations in CNPY3-knockout models

• Therapeutic considerations:

  • Explore whether restoring CNPY3 function can rescue neurological phenotypes

  • Investigate compensatory mechanisms in heterozygous models